Article Sidebar

PDF
Date Published: 25/04/2022
Abstract Views: 241
Views PDF: 148
DOI: https://doi.org/10.51298/vmj.v512i1.2243
Issue
Vol. 512 No. 1 (2022)
Section
Các bài báo
How to Cite
Xuân Hậu, N. ., & Xuân Hiền N. . (2022). CLINICOPATHOLOGICAL FEATURES OF RECURRENT THYROID CANCER. Vietnam Medical Journal, 512(1). https://doi.org/10.51298/vmj.v512i1.2243

CLINICOPATHOLOGICAL FEATURES OF RECURRENT THYROID CANCER

Nguyễn Xuân Hậu1,2,, Nguyễn Xuân Hiền2
1 Hanoi Medical University
2 Hanoi Medical University Hospital

Main Article Content

Abstract

Objective: to evaluate the clinicopathological features of recurrent thyroid cancer. Subjects and Methods: a retrospective combined with a prospective cohort study of 50 recurrent thyroid cancer patients treated by surgery at Hanoi Medical University Hospital from October 2017 to August 2021. Results: The mean age was 42.8 and the ratio of female/male was 8/1. The median time to relapse was 38.2 months, and most of the patients had asymptomatic. Recurrence occurred in local lymph nodes in 61.1% of cases. Ultrasound could detect lesions in 90.7% of patients. FNA gave a malignant result in 89.2% of cases. 80.6% of patients had elevated thyroglobulin, the positive whole-body scan results in 56.1%. PET/CT was performed in 33.3% of patients with 100% recurrence detected. Conclusion: Almost thyroid carcinoma is local recurrence, slight symtoms.

Article Details

Keywords

recurrent thyroid cancer, clinicopathological features

References

1. Deen MH, Burke KM, Janitz A, Campbell J. Cancers of the Thyroid: Overview and Statistics in the United States and Oklahoma. The Journal of the Oklahoma State Medical Association. 2016;109(7-8):333-338.
2. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]. Cancer. 1998;83(12):2638-2648.
3. Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World journal of surgery. 2002;26(8):879-885.
4. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. The American journal of medicine. 1994;97(5):418-428.
5. Chử Quốc Hoàn. Nhận xét một số đặc điểm lâm sàng, tỉ lệ các nhóm mô bệnh học và kết quả điều trị ung thư tuyến giáp tại Bệnh viện K. Trường đại học Y Hà Nội. 2013.
6. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer. 2003;97(1):90-96.
7. Trần Ngọc Hải. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị của bệnh ung thư giáp trạng tái phát tại bệnh viện K. Đại học Y Hà Nội, Hà Nội. 2008.
8. Trần Đặng Ngọc Linh, Đoàn Văn Lâm, Võ Khắc Nam. Xử trí hạch cổ tái phát, tồn tại trong ung thư tuyến giáp biệt hóa. Ung thư học Việt Nam. 2016;2.
9. Pino Rivero V, Montero García C, Marcos García M, Pando Pinto JM, Alvarez Domínguez J, Blasco Huelva A. [Treatment of thyroid cancer. Retrospective study and review of the literature]. Anales otorrinolaringologicos ibero-americanos. 2003;30(5):481-488.